Download Files:
DOTA Conjugated JM#21 derivative 7
For Research Use Only (RUO). This product is sold strictly for laboratory research use. Not for human or veterinary consumption, therapeutic, or diagnostic use.For sale to research organizations and laboratories only; not for patients or for personal use.
Products Details
Product Description
– DOTA-Conjugated JM#21 Derivative 7 (compound Ligand-7) is a CXCR4-targeting peptide derivative conjugated with DOTA, suitable for producing radioligands. Radiolabeled with 177Lu, this compound, referred to as 177Lu-DOTA, demonstrates superior CXCR4 tumor targeting capabilities. In vitro biodistribution studies of 177Lu-DOTA indicate minimal uptake in non-target organs, with the exception of the kidneys.
For Research Use Only (RUO). This product is sold strictly for laboratory research use only. Not for human or veterinary consumption, therapeutic, or diagnostic use. Any pharmacological, therapeutic, cosmetic, or biological effects described above are provided as research context only and do not represent intended or approved uses of this product.
Web ID
– TP2658
Storage Temperature
– -20℃
Shipping
– Blue Ice
Molecular Formula
– C66H114N22O16
CAS Number
– 3033865-40-3
Molecular Weight
– C66H114N22O16
SMILES
– C([C@H](NC([C@@H](NC([C@@H](NC([C@H]([C@H](CC)C)N)=O)CC(C)C)=O)CCCNC(=N)N)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CCCCNC(CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1)=O)C(N)=O)=O)CCCCN)=O)CCCNC(=N)N)=O)CO)=O)C=2C=3C(NC2)=CC=CC3
Product type
– Peptide
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
1000 in stock
Proudly representing
150+ years of combined research-supply heritage
